(NASDAQ:LFVN), SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2025. First Quarter Fiscal 2026 Summary*: Revenue was $47.6 million, an […]
(NasdaqGM:IMRX), – New case studies on first-line pancreatic cancer patients treated with atebimetinib in combination with FOLFIRINOX to be shared by trial investigators – – Conference call scheduled for Wednesday, November 12, 2025, at 4:30 pm ET – NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused
(NASDAQ:WEYS), MILWAUKEE, Nov. 04, 2025 (GLOBE NEWSWIRE) — Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended September 30, 2025. Third Quarter 2025 Overview Net sales: $73.1 million (down 2% from $74.3 million in Q3 2024) Gross earnings: 40.7% of net sales (compared to 44.3%
(NASDAQ:POOL), COVINGTON, La., Nov. 04, 2025 (GLOBE NEWSWIRE) — Pool Corporation (Nasdaq: POOL) announced today that it will participate in the following investor events in November 2025: November 11, 2025 – Baird 2025 Global Industrial Conference November 18, 2025 – Stephens Annual Investment Conference Investor-related materials and company information are available on the Investor Relations
(NasdaqGM:TARA), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has been named a BioSpace 2026 Best Place to Work. “Protara is thrilled to be recognized as one of the most sought-after biotech
(NASDAQ:OPRT), Meets or exceeds all third quarter guidance metrics GAAP Net income of $5.2 million reflects $35 million year-over-year improvement GAAP EPS of $0.11, up $0.86 versus prior-year period Adjusted EPS of $0.39, up sharply versus $0.02 in 3Q24 Operating expenses reduced 11% year-over-year, supporting continued margin expansion SAN CARLOS, Calif., Nov. 04, 2025 (GLOBE
(NASDAQ:CLOV), Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member base High coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong
(NASDAQ:NDAQ), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for October 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators
(NASDAQ:WKHS), ISS and Glass Lewis Both Recognize Compelling Value Transaction Delivers to Workhorse Shareholders Visit votewkhs.com for Information on How to Vote CINCINNATI, Nov. 04, 2025 (GLOBE NEWSWIRE) — Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced that leading
(NasdaqGM:KIDS), WARSAW, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in three upcoming investor conferences. Event: Stifel 2025 Healthcare Conference Format: